TMARKETVIEW_20050126.0711-E1-7	ORG 1535 1543	industry
TMARKETVIEW_20050126.0711-E2-9	PER 1341 1345	your
TMARKETVIEW_20050126.0711-E2-10	PER 1264 1265	I
TMARKETVIEW_20050126.0711-E2-17	PER 877 886	J. Nathan
TMARKETVIEW_20050126.0711-E3-12	PER 1106 1113	lawyers
TMARKETVIEW_20050126.0711-E4-13	PER 1444 1451	readers
TMARKETVIEW_20050126.0711-E5-1	ORG 141 146	Merck
TMARKETVIEW_20050126.0711-E5-18	ORG 363 367	they
TMARKETVIEW_20050126.0711-E5-19	ORG 390 394	they
TMARKETVIEW_20050126.0711-E5-20	ORG 526 531	Merck
TMARKETVIEW_20050126.0711-E5-21	ORG 674 679	Merck
TMARKETVIEW_20050126.0711-E5-24	ORG 819 823	they
TMARKETVIEW_20050126.0711-E5-31	ORG 1155 1159	they
TMARKETVIEW_20050126.0711-E6-8	PER 1744 1746	we
TMARKETVIEW_20050126.0711-E6-14	PER 1747 1755	Merckers
TMARKETVIEW_20050126.0711-E6-23	PER 499 508	investors
TMARKETVIEW_20050126.0711-E7-2	PER 1409 1410	I
TMARKETVIEW_20050126.0711-E7-3	PER 1421 1422	I
TMARKETVIEW_20050126.0711-E7-4	PER 1368 1369	I
TMARKETVIEW_20050126.0711-E7-5	PER 1454 1455	I
TMARKETVIEW_20050126.0711-E7-6	PER 1471 1472	I
TMARKETVIEW_20050126.0711-E7-11	PER 682 683	I
TMARKETVIEW_20050126.0711-E7-15	PER 112 117	Byrne
TMARKETVIEW_20050126.0711-E7-16	PER 1301 1306	Byrne
TMARKETVIEW_20050126.0711-E7-25	PER 733 734	I
TMARKETVIEW_20050126.0711-E7-26	PER 668 669	I
TMARKETVIEW_20050126.0711-E7-27	PER 765 766	I
TMARKETVIEW_20050126.0711-E7-28	PER 794 795	I
TMARKETVIEW_20050126.0711-E7-29	PER 913 916	you
TMARKETVIEW_20050126.0711-E7-30	PER 952 955	you
TMARKETVIEW_20050126.0711-E7-32	PER 1272 1275	you
TMARKETVIEW_20050126.0711-E7-33	PER 1280 1284	your
TMARKETVIEW_20050126.0711-E8-22	ORG 636 647	Wall Street
RMARKETVIEW_20050126.0711-R1-1	ORG-AFF Arg1:TMARKETVIEW_20050126.0711-E7-26 Arg2:TMARKETVIEW_20050126.0711-E5-21
